Biotech

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up

Cyclana Bio's PEMP study has received NHS ethics approval and begun enrolling women at two UK hospitals. If its tissue-first approach to drug discovery pays off, it could start answering questions that have gone unanswered for decades.

AviadoBio Bets on Blood-Brain Barrier Technology in Push for One-Time Alzheimer's Treatment

A licensing deal with Apertura Gene Therapy gives the London-based biotech a clinically validated delivery system to pair with its gene-silencing platform, but the hard work is still ahead.

Atelerix Launches STORganoid: Cryo-Free Ambient-Temperature Preservation for Organoids and Spheroids

Atelerix Launches STORganoid: Cryo-Free Ambient-Temperature Preservation for Organoids and Spheroids.

Andelyn Biosciences and Evolyra Therapeutics Join Forces to Advance Gene Therapies for Limb-Girdle Muscular Dystrophy

A new CDMO partnership aims to bring clinical-grade AAV gene therapies to patients with LGMD types 2C and 2D, with an IND filing targeted for the second half of 2026

The Future of Medicine is in Your DNA

An overview of gene therapy's history, recent breakthroughs, and what it's future may look like.

Virica Biotech and FUJIFILM Biosciences partner to improve AAV manufacturing efficiency

Collaboration under Canada–Japan programme targets higher yields and scalable processes for gene therapy production.